Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.
Candel Therapeutics' CAN-2409 extended survival in NSCLC patients, with biomarker data showing enhanced response in ...
Tumor DNA in the Blood Can Predict Lung Cancer Outcome Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts ...
Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial ...
TAIPEI (Taiwan News) — A study by Chang Gung Memorial Hospital has discovered that removing the amino acid asparagine from ...